Literature DB >> 8698502

Studies of immunity and bacterial invasiveness in mice given a recombinant salmonella vector encoding murine interleukin-6.

S J Dunstan1, A J Ramsay, R A Strugnell.   

Abstract

Interleukin-6 (IL-6) was expressed in Salmonella typhimurium in an attempt to increase the mucosal immune response against the bacterium. Murine IL-6 was PCR amplified from cDNA, cloned, sequenced, and found to be functionally active when expressed in S. typhimurium BRD509, the (delta)aroA (delta)aroD vaccine strain. Expression of murine IL-6 did not appear to adversely affect the growth of salmonellae, as the construct was retained in the absence of antibiotic selection and the growth rate was unaffected compared with that of the parent strain in vitro. However, IL-6 expression led to a significant reduction in bacterial invasiveness in vitro and in vivo. Splenocytes and small intestinal lamina propria lymphocytes were isolated from mice orally immunized with BRD509 expressing IL-6 (pKK233-2/IL-6), and the number of antibody-secreting cells was determined by the ELISPOT technique. No differences were observed between mice immunized with BRD509(pKK.233-2/IL-6) and those immunized with BRD509(pKK233-2) with respect to the antibody subclass-specific responses elicited despite the markedly reduced invasiveness of the former. Serum antibody responses were also examined by a kinetic enzyme-linked immunosorbent assay (ELISA), and equivalent levels of antibody response were detected in mice given BRD509(pKK233-2/IL-6) and those given BRD509(pKK233-2). The humoral immune response against bacterial lipopolysaccharides was also examined in transgenic IL-6-deficient mice given oral inocula of BRD509. Equivalent numbers of antibody-secreting cells (ELISPOTs) were observed in the spleens and laminae propriae of both IL-6-deficient (-/-) mice and control (+/+) mice harboring an intact IL-6 gene, whereas small, yet significant differences in the serum immunoglobulin A ELISA titers were observed. These data suggest that the immunoglobulin A response against Salmonella lipopolysaccharides is largely IL-6 independent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698502      PMCID: PMC174133          DOI: 10.1128/iai.64.7.2730-2736.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Immune responses in BALB/c mice following immunization with aromatic compound or purine-dependent Salmonella typhimurium strains.

Authors:  D O'Callaghan; D Maskell; J Tite; G Dougan
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

2.  "ATG vectors' for regulated high-level expression of cloned genes in Escherichia coli.

Authors:  E Amann; J Brosius
Journal:  Gene       Date:  1985       Impact factor: 3.688

3.  IgA production by peritoneal cavity B cells is IL-6 independent: implications for intestinal IgA responses.

Authors:  K W Beagley; S Bao; A J Ramsay; J H Eldridge; A J Husband
Journal:  Eur J Immunol       Date:  1995-07       Impact factor: 5.532

4.  A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells.

Authors:  J D Sedgwick; P G Holt
Journal:  J Immunol Methods       Date:  1983-02-25       Impact factor: 2.303

5.  Salmonella typhimurium LT2 strains which are r- m+ for all three chromosomally located systems of DNA restriction and modification.

Authors:  L R Bullas; J I Ryu
Journal:  J Bacteriol       Date:  1983-10       Impact factor: 3.490

6.  Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier.

Authors:  N F Fairweather; S N Chatfield; A J Makoff; R A Strugnell; J Bester; D J Maskell; G Dougan
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

7.  Multiple biological activities are expressed by a mouse interleukin 6 cDNA clone isolated from bone marrow stromal cells.

Authors:  C P Chiu; C Moulds; R L Coffman; D Rennick; F Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

8.  Production of hybridoma growth factor by human monocytes.

Authors:  L A Aarden; E R De Groot; O L Schaap; P M Lansdorp
Journal:  Eur J Immunol       Date:  1987-10       Impact factor: 5.532

9.  Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune systems.

Authors:  D J Maskell; K J Sweeney; D O'Callaghan; C E Hormaeche; F Y Liew; G Dougan
Journal:  Microb Pathog       Date:  1987-03       Impact factor: 3.738

10.  Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells.

Authors:  K W Beagley; J H Eldridge; F Lee; H Kiyono; M P Everson; W J Koopman; T Hirano; T Kishimoto; J R McGhee
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

View more
  4 in total

1.  Influence of vector-encoded cytokines on anti-Salmonella immunity: divergent effects of interleukin-2 and tumor necrosis factor alpha.

Authors:  B K al-Ramadi; M H Al-Dhaheri; N Mustafa; M Abouhaidar; D Xu; F Y Liew; M L Lukic; M J Fernandez-Cabezudo
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  The immunoregulation of mice by somatic transgenic expression of porcine interleukin-6 gene and CpG sequence.

Authors:  Jiangling Li; Rong Gao; Mei Wu; Mingjie Meng; Manshu Tang; Yi Shen; Lihuan Wang; Xueyan Wu; Xue Yin; Hongguan Xie; Shigui Liu
Journal:  Vet Res Commun       Date:  2004-01       Impact factor: 2.816

3.  CXCR3 plays a critical role for host protection against Salmonellosis.

Authors:  Belal Chami; Amanda Yeung; Michael Buckland; Hongjun Liu; Genevieve M Fong; Kun Tao; Shisan Bao
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

4.  Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine.

Authors:  L Steidler; K Robinson; L Chamberlain; K M Schofield; E Remaut; R W Le Page; J M Wells
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.